Project has tracked lives, lifestyles, and well-being of cohorts over decades, led to insights, interventions in cardiovascular disease, cancers, nutrition
A new study led by Harvard researchers models future SARS-CoV-2 mutations and forecasts their ability to evade immune defenses developed by vaccines and antibody-based treatments.
With Omicron landing in the U.S. this week, Harvard epidemiologist William Hanage reviewed what we know and the many things still unknown about the fast-moving coronavirus variant.
Breakthrough COVID-19 cases in vaccinated people may be less likely to spread infection because virus is shed for a shorter period of time as opposed to infections in unvaccinated people.
In a comparison study, the Moderna vaccine was slightly more effective than the Pfizer vaccine in preventing COVID-19 infection, hospitalization, and death.
A Harvard expert shares insight on the science and history of vaccine boosters and why we need them, speculating on a future that includes periodic COVID boosters.
Study says that physical activity later in life shifts energy away from processes that compromise health and toward mechanisms in the body that extend it.
A second untreated person living with HIV shows no evidence of intact HIV genomes, indicating that her immune system may have eliminated the HIV reservoir.
Researchers have developed an artificial intelligence-based method to predict the risk of atrial fibrillation within the next five years based on results from electrocardiograms.
One hundred years after the discovery of insulin, replacement therapy represents “a new kind of medicine,” says Douglas Melton, co-director of Harvard Stem Cell Institute.
Baby teeth may reveal clues about the effects of childhood adversity, which research suggests is responsible for up to one-third of all mental health disorders.
A new decision-support tool helped preserve the health care workforce by distinguishing symptoms associated with COVID-19 vaccinations from symptoms of the virus itself.
Featured series 
Audio
